Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.

Antimicrobial agents and chemotherapy - 20 Aug 2020

Khalifa Hazim O, Arai Teppei, Majima Hidetaka, Watanabe Akira, Kamei Katsuhiko

Abstract excerpt

Infections caused by Candida glabrata have caused worldwide concern, especially when they are associated with increasing echinocandin and azole resistance. In this study, we analyzed the molecular mechanisms of azole and echinocandin resistance in C. glabrata isolates obtained from hospitalized patients in Japan from 1997 to 2019. All isolates were checked phenotypically for resistance and genotypically for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Azoles
Share to Candida glabrata

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Fungal

Share to Echinocandins

Share to Fungal Proteins

Share to Multilocus Sequence Typing

Source

Open in PubMed Open full text

Identifiers

PMID: 32571826
DOI: 10.1128/AAC.00783-20
PMCID: PMC7449192

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.PMID 32571826Read ↗

Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China.Semantic proximity Read ↗

Emergence of invasive candidiasis with multiple Candida species exhibiting azole and echinocandin resistanceSemantic proximity Read ↗

Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpressionSemantic proximity Read ↗

Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.Semantic proximity Read ↗

Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure.Semantic proximity Read ↗

Drug susceptibility profile of Candida glabrata clinical isolates from Iran and genetic resistant mechanisms to caspofungin.Semantic proximity Read ↗

Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.Semantic proximity Read ↗

Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center StudySemantic proximity Read ↗

Prevalence of Antifungal Resistance, Genetic Basis of Acquired Azole and Echinocandin Resistance, and Genotyping of Candida krusei Recovered from an International Collection.Semantic proximity Read ↗

Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida SpeciesSemantic proximity Read ↗

Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrataSemantic proximity Read ↗

Antifungal susceptibility, molecular epidemiology, and clinical risk factors of Candida glabrata in intensive care unit in a Chinese Tertiary Hospital.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.